ScreenerHero

SYBXSynlogic, Inc.

NAS · US · Healthcare · Biotechnology · synlogictx.com
1.200USD-2.44%Mkt Cap: 14.70M $P/E: —

Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap14.70M $
Enterprise Value1.76M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-1.00M $
Revenue/Share—
Last Price1.200 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS87166L1008
Valuation
P/E (Trailing)—
P/E (Forward)-2.60
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B1.19
EPS (TTM)-0.05
EPS (Forward)-0.47
52W Range
0.540050% of range1.870
52W High1.870 USD
52W Low0.5400 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-8.47%
ROA-6.51%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.36M $
CapEx (TTM)—
FCF Margin—
FCF Yield-39.24%
Net Debt-13.18M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio9.19
Quick Ratio9.02
Book Value/Sh1.027 USD
Cash/Share1.076 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateAug 28, 2017
Splits
Last Split1:7
Split DateAug 28, 2017
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.12.25M
Float3.65M
Insiders15.65%
Institutions57.55%
Short Interest
Short Ratio0.1d
Short % Float0.20%
Short % Out.0.09%
Shares Short10.41K
Short (prev mo.)15.43K
Technical
SMA 500.8730 (+37.5%)
SMA 2000.8751 (+37.1%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)72.48K
Avg Vol (10d)27.16K
Technical Indicators
RSI (14)66.2
MACD0.1244
MACD Signal0.1268
MACD Hist.-0.0024
BB Upper1.515 USD
BB Middle1.068 USD
BB Lower0.6215 USD
BB Width83.62%
ATR (14)0.0749 USD
Vol Ratio (20d)0.20x